PNC Financial Services Group
LTRN icon

PNC Financial Services Group’s Lantern Pharma LTRN Stock Holding History

PNC Financial Services Group’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-250
Closed -$2.2K – 4854
2024
Q1 		$2.2K Buy
+250
New +$1.34K ﹤0.01% 4170

Other funds holding LTRN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PNC Financial Services Group's LTRN Position: Q2 2024 in Review

PNC Financial Services Group sold out of Lantern Pharma (LTRN) in Q2 2024, closing a stake of 250 shares — an estimated $2.2K sold.

PNC Financial Services Group first reported a position in LTRN in Q1 2024 and held it in 1 quarter. The position peaked at $2.2K in Q1 2024. 39 funds tracked by Wall St. Rank hold LTRN as of Q2 2024.

  • PNC Financial Services Group reported no remaining Lantern Pharma position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 250 Lantern Pharma shares in Q2 2024, an estimated $2.2K.
  • PNC Financial Services Group first reported a position in Lantern Pharma in Q1 2024 and held it in 1 quarter.
  • PNC Financial Services Group's Lantern Pharma position peaked at $2.2K in Q1 2024.
  • 39 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.